Coronary stent thrombosis in Patients undergoing multidigit replantation

Critical Care Medicine

Volumn 40, Issue 1, 2012, Pages 285-289

  Jacobs, Jordan ^a   Shah, Alan ^a   Zinn, Andrew ^a   Levine, Jamie ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug eluting stent; In stent thrombosis; Multidigit replantation

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYPHER; FENTANYL; HEPARIN; PROPOFOL; RAPAMYCIN; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CORONARY STENT; DRUG ELUTING STENT; DUAL ANTIPLATELET THERAPY; EMERGENCY SURGERY; FASCIOTOMY; FINGER AMPUTATION; FINGER INJURY; HAND SURGERY; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; LEECHING; MALE; MORNING DOSAGE; PERCUTANEOUS CORONARY INTERVENTION; PHARMACOGENETICS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN GRAFT; STENT THROMBOSIS;

ADULT; AMPUTATION, TRAUMATIC; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FINGER INJURIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; REPLANTATION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84155167221     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31822d7da7     Document Type: Article

References (38)

1. Fleisher LA, Beckman JA, Brown KA, et al: ACC/AHA 2007. Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 2007; 50: e159-e242
2. Malenka D, Kaplan AV, Lucas FL, et al: Outcomes following coronary stenting in the era of baremetal vs. The era of drug-eluting stents. JAMA 2008; 299:2868-2876
3. Iakovou I, Schmidt T, Bonizzoni E, et al: Incidence, predictors and outcome of thrombosis after successful implantation of drug eluting stents. JAMA 2005; 293:2126-2130
4. Urban P, Gershlick AH, Guagliumi G, et al: Safety of coronary sirolimus-eluting stents in daily clinical practice: One-year follow-up of the e-Cypher registry. Circulation 2006; 113: 1434-1441
5. Barvry AA, Kumbhani DJ, Helton TJ, et al: Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials. Am J Med 2006; 119:1056-1061
6. Eisenberg MJ, Richard PR, Libersan D, et al: Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 2009; 119:1634-1642
7. Compton PA, Zankar AA, Adesanya AO, et al: Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol 2006; 98:1212-1213
8. Schouten O, van Domburg RT, Bax JJ, et al: Noncardiac surgery after coronary stenting: Early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007; 49:122-124
9. Godet D, Manach YL, Lesache F, et al: Drug eluting stent thrombosis in patients undergoing noncardiac surgery: Is it always a problem? BJ Anaesth 2008; 100:472-477
10. Rhee SJ, Yun KH, Lee SR, et al: Drug-eluting stent thrombosis during perioperative period. Int Heart J 2008; 49:135-142
11. Mcfalls EO, Ward HB, Moritz TE, et al: Coronary artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795-2804
12. Grines CL, Bonow RO, Casey DE Jr, et al: Prevention of premature discontinuation of antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology Society of Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 115:813-818
13. Eikelboom JW, Hirsch J: Bleeding and management of bleeding. Eur Heart J 2006; 8:G38-G45
14. Yusef S, Zhao F, Mehta SR, et al: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes. N Eng J Med 20013; 45:494-502
15. Doyle BJ, Rihal CS, Gastineau DA, et al: Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention. J Am Coll Cardiol 2009; 53: 2019-2027
16. Khorana AA, Francis CW, Blumberg N, et al: Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 2008; 168:2377-2381
17. Berezina TL, Zaets SB, Morgan C, et al: The impact of storage on red cell function in blood transfusion. J Surg Res 2002; 102:6-12
18. Twomley KM, Rao SV, Becker RC: Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis 2006; 21:167-174
19. Sibbing D, Koch W, Gebhard D, et al: 2C19 17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement. Circulation 2010; 121: 512-518
20. Holms DR, Dehmer GJ, Kaul S, et al: ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA 'boxed warning.' A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association. Circulation 2010; 122:537-555
21. Collet JP, Hulot JS, Pena A, et al: Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: A cohort study. Lancet 2009; 373:309-317
22. Giusti B, Gori AM, Marcucci R, et al: Relation of cytochrome P450 2 C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis. Am J Cardiol 2009; 103:806-811
23. Shuldiner AR, O'Connell JR, Bliden KP, et al: Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA 2009; 302:849-857
24. Simon T, Verstuyft C, Mary-Krause M, et al: French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009; 360: 363-375
25. Mega JL, Close SL, Wiviott SD, et al: Cytochrome p-450 polymorphism and response to clopidogrel. N Eng J Med 2009; 360: 354-362
26. Pare G, Metha SR, Yusuf S, et al: Effect of CYP2C19 genotype on outcomes of clopidogrel treatment. N Eng J Med 2010; 363: 1704-1714
27. Last EJ, Sheehan AH: Review of recent evidence: Potential interaction between clopidogrel and proton pump inhibitors. Am J Health Syst Pharm 2009; 66:2117-2122
28. Abraham NS, Hlatky MA, Antman EM, et al: ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: A focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. J Am Coll Cardiol 2010; 56:2051-2066
29. Lau WC, Gurbel PA, Watkins PB, et al: Saint Johns wort enhances clopidogrel responsiveness in clopidogrel resistance in volunteers and patients by induction of CYP3a4 isoenzymes. Abstr. J Am Coll Cardiol 2007; 49(Suppl):343A
30. Bliden KP, DiChiara J, Looklam L, et al: The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. J Am Coll Cardiol 2008; 52:5310-5313
31. Price MJ: Bedside evaluation of thienopyridine antiplatelet therapy. Circulation 2009; 119:2625-2632
32. Bonello L, Armero S, Mokhtar OA, et al: Clopidogrel load dose adjustments according to platelet reactivity monitoring in patients carrying the 2C19 2 loss of function polymorphism. J Am Coll Cardiol 2010; 56: 160-166
33. Farid NA, Payne CD, Small DS, et al: Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently. Clin Pharmacol Ther 2007; 81:735-741
34. Wiviottt SD, Braunwald E, McCabe CH, et al: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Eng J Med 2007; 357:2001-2015
35. Greenbaum AB, Grines CL, Bittl JA, et al: Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: Results from a 2-part, phase II, multicenter, randomized, placebo-and activecontrolled trial. Am Heart J 2006; 151:
36. 1-689.e10.
37. Catteno M: New P2Y12 inhibitors. Circulation 2010; 121:171-179
38. Pompilo G, Capogrossi M ,Pesce M, et al: Endothelial progenitor cells and cardiovascular homeostasis: Clinical implications. Int J Cardiol 2009; 131:156-167